Diagnosing the decline in pharmaceutical R&D efficiency

JW Scannell, A Blanckley, H Boldon… - Nature reviews Drug …, 2012 - nature.com
The past 60 years have seen huge advances in many of the scientific, technological and
managerial factors that should tend to raise the efficiency of commercial drug research and …

Leading pharmaceutical innovation

O Gassmann, G Reepmeyer, M Von Zedtwitz - Berlin: Springer. https://doi …, 2008 - Springer
The life sciences have never been an easy industry, and they are about to become even
more treacherous to navigate. New technologies speed up innovation, new competitors …

[图书][B] The business of healthcare innovation

LR Burns - 2012 - books.google.com
The Business of Healthcare Innovation is a wide-ranging analysis of business trends in the
manufacturing segment of the healthcare industry. It provides a thorough overview and …

Organizing pharmaceutical innovation: from science‐based knowledge creators to drug‐oriented knowledge brokers

O Gassmann, G Reepmeyer - Creativity and Innovation …, 2005 - Wiley Online Library
The pharmaceutical industry is exposed to severe conditions: while a typical R&D process
lasts up to 13 years, only one out of 10,000 substances becomes a marketable product. In …

Knowledge arbitrage in global pharma: a synthetic view of absorptive capacity and open innovation

B Hughes, J Wareham - R&d Management, 2010 - Wiley Online Library
This case study examines a global pharmaceutical company widely using open innovation
(OI). Three main research questions are addressed:(1) what OI concepts are salient in their …

[PDF][PDF] Pharmaceutical marketing mix strategy and physician's prescription behavior

RR Ahmed - The Pharma Innovation, 2014 - researchgate.net
Purpose: This research paper gives an insight about the processes used by local and MNCs
pharmaceutical companies in Pakistan. The purpose of our research is to examine that what …

The communication mix in pharmaceutical marketing

R Ahmed, P Vishnu, N Ahmad… - The Pharma …, 2014 - papers.ssrn.com
The development of effective communication Mix in Pharmaceutical marketing is a complex
task, which goes through identifying the target audience, determining the communication …

Are we all global now? Local vs. foreign sources of corporate competence: the case of the Japanese pharmaceutical industry

LG Thomas III - Strategic Management Journal, 2004 - Wiley Online Library
This study links the highly distinctive national contexts of the pharmaceutical industry to the
evolution of innovative capabilities for Japanese drug firms from 1975 to 1995. During these …

[图书][B] Risk-sharing in the pharmaceutical industry: The case of out-licensing

G Reepmeyer - 2006 - books.google.com
The productivity in pharmaceutical research and development faces intense pres sure. R&D
expenditures of the major US and European companies have topped US $33 billion in 2003 …

[图书][B] Building biotechnology: Starting, managing, and understanding biotechnology companies

Y Friedman - 2006 - scholar.archive.org
Building Biotechnology: Starting, Managing, and Understanding Biotechnology Companies*
Page 1 Electronic Journal of Biotechnology ISSN: 0717-3458 Vol.8 No.1, Issue of April 15 …